| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Senior Vice President And CFO
2 companies
Staab Thomas R II is a Chief Financial Officer at LNSR, with reported holdings spanning 2 companies. Recent filings cover 2 purchases and 39 sales. Those positions are worth an estimated $2.6M at current prices.
Staab Thomas R II's largest disclosed position is in LNSR as Chief Financial Officer, worth about $1.4M. Net of sales, the recent Form 4 record there shows accumulation of 2,752 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2016 | BCRX Biocryst Pharmaceuticals Inc | Senior Vice President And CFO | Sell | 5,864 | $5.18 | $30,388.06 | -2.3% | |
| Aug 9, 2016 | BCRX Biocryst Pharmaceuticals Inc | Senior Vice President And CFO | Sell | 14,577 | $4.43 | $64,576.11 | -10.1% | |
| Dec 21, 2015 | BCRX Biocryst Pharmaceuticals Inc | Senior Vice President And CFO | Sell | 3,052 | $10.86 | $33,144.72 | -2.2% | |
| Dec 17, 2015 | BCRX Biocryst Pharmaceuticals Inc | Senior Vice President And CFO | Sell | 3,000 | $10.49 | $31,470.00 | -2.1% |